Great article from Insider Trading.....to say VCR is on the radar, would be an understatement!
The US Health Care System warrants LVAD therapy, for the following reason.......
"In the major market of the United States, health and insurance authorities are currently reimbursing the cost of systems similar to the VentrAssist™. The VentrAssist™ system and cost of the operation are potentially much less than the comparative cost of keeping a heart failure patient in intensive care and also less than the total cost of a heart transplant over a patient's lifetime, due to the greatly reduced need for drug therapy such as immune system suppression drugs.
Ventracor’s competitive advantage is its rotary device using hydrodynamic levitation. The robust simplicity of its design, its outstanding bio-compatibility, a unique patented hydrodynamic impeller, small size and affordability set it apart from the other devices."
### Big night ahead........the pending recommendation would be just as effective as announcing Unconditional approv........Mon could see the 90's!!!
VCR Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.